Nicotine-mediated cell proliferation and angiogenesis: New twists to an old story

Cell Cycle

Volumn 5, Issue 20, 2006, Pages 2324-2328

  Dasgupta, Piyali ^a   Chellappan, Srikumar P ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cell cycle; E2F; Non small cell lung cancer; Raf 1; Rb; Src; arrestin 1

Indexed keywords

BETA ARRESTIN 1; NICOTINE; NUCLEAR RECEPTOR COACTIVATOR 2; RETINOBLASTOMA PROTEIN; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3;

ANGIOGENESIS; APOPTOSIS; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; HUMAN; REVIEW;

NICOTIANA TABACUM;

EID: 33751336914     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.20.3366     Document Type: Review

References (53)

1. Johnson BE. Tobacco and lung cancer. Prim Care 1998; 25:279-91.
2. Bepler G. Lung cancer: Provoking new concepts, generating novel ideas, and rekindling enthusiasm. Cancer Control 2003; 10:275-6.
3. ACS. Cancer facts and figures. American Cancer Society, 2002.
4. Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer 2003; 98:632-44.
5. Zhou W, Heist RS, Liu G, Park S, Neuberg DS, Asomaning K, Wain JC, Lynch TJ, Christiani DC. Smoking cessation before diagnosis and survival in early stage nonsmall cell lung cancer patients. Lung Cancer 2006; 53:375-80.
6. Hecht SS. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 1999; 424:127-42.
7. Brunnemann KD, Prokopczyk B, Djordjevic MV, Hoffmann D. Formation and analysis of tobacco-specific N-nitrosamines. Crit Rev Toxicol 1996; 26:121-37.
8. Schuller HM, Orloff M. Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem Pharmacol 1998; 55:1377-84.
9. Itier V, Bertrand D. Neuronal nicotinic receptors: From protein structure to function. FEBS Lett 2001; 504:118-25.
10. Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol 1997; 15:193-222.
11. Sharma G, Vijayaraghavan S. Nicotinic receptor signaling in nonexcitable cells. J Neurobiol 2002; 53:524-34.
12. Schuller HM, Tithof PK, Williams M, Plummer IIIrd H. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. Cancer Res 1999; 59:4510-5.
13. Schuller HM, Porter B, Riechert A. Beta-adrenergic modulation of NNK-induced lung carcinogenesis in hamsters. J Cancer Res Clin Oncol 2000; 126:624-30.
14. Jull BA, Plummer HK, Schuller H. Nicotinic receptor-mediated activation by tobacco-specific nitrosamine NNK of a Raf-1/MAPkinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma and pulmonary neuroendocrine cells. J Cancer Res clin Oncol 2001; 127:707-17.
15. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke JP. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nature Medicine 2001; 7:833-9.
16. Heeschen C, Weis M, Aicher A, Dimmler S, Cooke JP. A novel angiogenic pathway mediated by nonneuronal nicotinic acetylcholine receptors. J Clin Invest 2002; 110:527-36.
17. Heeschen C, Weis M, Cooke JP. Nicotine promotes arteriogenesis. J Am Coll Cardiol 2003; 41:489-96.
18. Wessler I, Kirkpatrick CJ, Racke K. Nonneuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: Expression and function in humans. Pharmacol Ther 1998; 77:59-79.
19. Villablanca AC. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 1998; 84:2089-98.
20. Cattaneo MG, D'Atri F, Vicentini LM. Mechanisms of mitogen-activated protein kinase activation by nicotine in small-cell lung carcinoma cells. Biochem J 1997; 328(Pt 2):499-503.
21. Schuller HM, Plummer IIIrd HK, Jull BA. Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells. Anat Rec 2003; 270A:51-8.
22. Minna JD. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest 2003; 111:31-3.
23. Trombino S, Cesario A, Margaritora S, Granone P, Motta G, Falugi C, Russo P. alpha7-Nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: Role of mitogen-activated protein kinase pathway. Cancer Res 2004; 64:135-45.
24. Trombino S, Bisio A, Carassi A, Cesario A, Falugi C, Russo P. Role of the nonneuronal human cholinergic system in lung cancer and mesothelioma: Possibility of new therapeutic strategies. Curr Med Chem Anti-Canc Agents 2004; 4:535-42.
25. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest 2003; 111:81-90.
26. West KA, Linnoila IR, Brognard J, Belinsky S, Harris C, Dennis PA. Tobacco carcinogen-induced cellular transformation increases Akt activation in vitro and in vivo. Chest 2004; 125:101S-2S.
27. West KA, Linnoila IR, Belinsky SA, Harris CC, Dennis PA. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3′-kinase/Akt pathway in vitro and in vivo. Cancer Res 2004; 64:446-51.
28. Swope SL, Huganir RL. Binding of the nicotinic acetylcholine receptor to SH2 domains of Fyn and Fyk protein tyrosine kinases. J Biol Chem 1994; 269:29817-24.
29. Swope SL, Qu Z, Huganir RL. Phosphorylation of the nicotinic acetylcholine receptor by protein tyrosine kinases. Ann NY Acad Sci 1995; 757:197-214.
30. Wang K, Hackett JT, Cox ME, Van Hoek M, Lindstrom JM, Parsons SJ. Regulation of the neuronal nicotinic acetylcholine receptor by SRC family tyrosine kinases. J Biol Chem 2004; 279:8779-86.
31. Mohamed AS, Swope SL. Phosphorylation and cytoskeletal anchoring of the acetylcholine receptor by Src class protein-tyrosine kinases. Activation by rapsyn. J Biol Chem 1999; 274:20529-39.
32. Kumar P, Meizel S. Nicotinic acetylcholine receptor subunits and associated proteins in human sperm. J Biol Chem 2005; 280:25928-35.
33. Charpantier E, Wiesner A, Huh KH, Ogier R, Hoda JC, Allaman G, Raggenbass M, Feuerbach D, Bertrand D, Fuhrer C. Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. J Neurosci 2005; 25:9836-49.
34. Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, Haura E, Chellappan S. Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest 2006; 116:2208-17.
35. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science 2005; 308:512-7.
36. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 1999; 283:655-61.
37. van Koppen CJ. Multiple pathways for the dynamin-regulated internalization of muscarinic acetylcholine receptors. Biochem Soc Trans 2001; 29:505-8.
38. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci USA 2006; 103:1492-7.
39. Kang J, Shi Y, Xiang B, Qu B, Su W, Zhu M, Zhang M, Bao G, Wang F, Zhang X, Yang R, Fan F, Chen X, Pei G, Ma L. A nuclear function of beta-arrestin1 in GPCR signaling: Regulation of histone acetylation and gene transcription. Cell 2005; 123:833-47.
40. Nevins JR. The Rb/E2F pathway and cancer. Hum Mol Genet 2001; 10:699-703.
41. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81:323-30.
42. Wang S, Ghosh RN, Chellappan SP. Raf-1 physically interacts with Rb and regulates its function: A link between mitogenic signaling and cell cycle regulation. Mol Cell Biol 1998; 18:7487-98.
43. Dasgupta P, Sun J, Wang S, Fusaro G, Betts V, Padmanabhan J, Sebti SM, Chellappan S. Disruption of the Rb-Raf-1 interaction inhibits tumor growth and angiogenesis. Molecular Cellular Biology 2004; 24:9527-41.
44. 1 cell cycle transition. J Biol Chem 2005; 280:6369-79.
45. Zhu BQ, Heeschen C, Sievers RE, Karliner JS, Parmley WW, Glantz SA, Cooke JP. Second hand smoke stimulates tumor angiogenesis and growth. Cancer Cell 2003; 4:191-6.
46. Phung TL, Ziv K, Dabydeen D, Eyiah-Mensah G, Riveros M, Perruzzi C, Sun J, Monahan-Earley RA, Shiojima I, Nagy JA, Lin MI, Walsh K, Dvorak AM, Briscoe DM, Neeman M, Sessa WC, Dvorak HF, Benjamin LE. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell 2006; 10:159-70.
47. Conklin BS, Zhao W, Zhong D, Chen C. Nicotine and Cotinine upregulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol 2002; 160:413-9.
48. Shin VY, Wu WK, Chu KM, Wong HP, Lam EK, Tai EK, Koo MW, Cho CH. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Mol Cancer Res 2005; 3:607-15.
49. Alavi A, Hood JD, Frausto R, Stupack DG, Cheresh DA. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 2003; 301:94-6.
50. Hood JD, Cheresh DA. Targeted delivery of mutant Raf kinase to neovessels causes tumor regression. Cold Spring Harb Symp Quant Biol 2002; 67:285-91.
51. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994; 269:10444-50.
52. Qin G, Kishore R, Dolan CM, Silver M, Wecker A, Luedemann CN, Thorne T, Hanley A, Curry C, Heyd L, Dinesh D, Kearney M, Martelli F, Murayama T, Goukassian DA, Zhu Y, Losordo DW. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci USA 2006; 103:11015-20.
53. Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 2006; 103:6332-7.